Patients with radiographic axial spondyloarthritis (ax-SpA) and a high risk of radiographic progression had similar low progression on both secukinumab and an adalimumab biosimilar.
Kimberly Rath, PharmD
Advertisement
Kimberly Rath, PharmD, is a freelance health writer who previously worked as a clinical pharmacist with Elevance Health for a decade. She has also worked for Amerigroup and Sentara Group.
Articles by Kimberly Rath, PharmD
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
RSV Vaccination Effective in Older Adults, but Protection Declines Over Time
2
Discontinuing GLP-1s Before or Early in Pregnancy Tied to Weight Gain, Pregnancy Complications
3
Tapinarof Shows Strong Efficacy, Sleep Benefits in Pediatric AD Across Comorbidities: Druhan Howell, MD
4
Defining Relapse and Switching Therapies in Multiple Myeloma
5
